Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC

#Spartalizumab in combination with platinum-doublet chemotherapy with or without #canakinumab in patients with PD-L1-unselected, metastatic NSCLC scientiasalut.gencat.cat/handle/11351... #ScientiaVH